• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾功能不全对急性冠状动脉综合征患者预后的影响。

Impact of Renal Insufficiency on Prognosis of Patients with Acute Coronary Syndrome.

作者信息

Qi Lingyao, Liu Hanxiong, Cheng Lianchao, Cui Caiyan, Chen Xu, Yang Siqi, Cai Lin

机构信息

Department of Cardiology, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, People's Republic of China.

出版信息

Int J Gen Med. 2021 Nov 26;14:8919-8927. doi: 10.2147/IJGM.S334014. eCollection 2021.

DOI:10.2147/IJGM.S334014
PMID:34866933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8633847/
Abstract

PURPOSE

Chronic kidney disease (CKD) is common in patients admitted with acute coronary syndrome (ACS), and it is associated with poor outcomes. However, data are limited. Hence, we examined the long-term prognostic significance of estimated glomerular filtration rate (eGFR) among Chinese patients hospitalized with ACS.

PATIENTS AND METHODS

This is a multicenter, observational study that included 1860 ACS patients enrolled between March 2014 and June 2019 from 11 hospitals in Chengdu. CKD-EPI equation was used to calculate the baseline eGFR. Patients were divided into three groups: eGFR ≥ 90 mL/min (normal renal function), eGFR 60 to <90 mL/min (mild impaired renal function), and eGFR < 60 mL/min (moderate or severe renal dysfunction). The endpoint was all-cause death during follow-up.

RESULTS

At baseline, 714 patients had normal renal function, while 746 patients had mild impaired renal function, and 400 patients had moderate or severe renal dysfunction. In the follow-up of 15 months (10 months, 22 months), 261 (14.0%) patients died;, 139 (34.8%) in the moderate or severe renal dysfunction group, 94 (12.6%) in the mild impaired renal function group, and 28 (3.9%) in the normal renal function group (log-rank p-value from Kaplan-Meier analysis <0.001). In multivariable Cox Proportional hazard analysis, age, systolic blood pressure (SBP), heart rate, eGFR, ST-elevation myocardial infarction (STEMI), and percutaneous coronary intervention (PCI) were independent predictors of all-cause death.

CONCLUSION

In this study, among Chinese patients with ACS, renal insufficiency was associated with unfavorable long-term prognosis. Age, SBP, heart rate, eGFR, STEMI, and PCI could identify those at risk.

摘要

目的

慢性肾脏病(CKD)在急性冠脉综合征(ACS)住院患者中很常见,且与不良预后相关。然而,相关数据有限。因此,我们研究了估算肾小球滤过率(eGFR)在中国ACS住院患者中的长期预后意义。

患者与方法

这是一项多中心观察性研究,纳入了2014年3月至2019年6月期间来自成都11家医院的1860例ACS患者。采用CKD-EPI方程计算基线eGFR。患者分为三组:eGFR≥90 mL/分钟(肾功能正常)、eGFR 60至<90 mL/分钟(轻度肾功能受损)、eGFR<60 mL/分钟(中度或重度肾功能不全)。终点为随访期间的全因死亡。

结果

基线时,714例患者肾功能正常,746例患者轻度肾功能受损,400例患者中度或重度肾功能不全。在15个月(10个月,22个月)的随访中,261例(14.0%)患者死亡;中度或重度肾功能不全组139例(34.8%),轻度肾功能受损组94例(12.6%),肾功能正常组28例(3.9%)(Kaplan-Meier分析的对数秩p值<0.001)。在多变量Cox比例风险分析中,年龄、收缩压(SBP)、心率、eGFR、ST段抬高型心肌梗死(STEMI)和经皮冠状动脉介入治疗(PCI)是全因死亡的独立预测因素。

结论

在本研究中,中国ACS患者中,肾功能不全与不良的长期预后相关。年龄、SBP、心率、eGFR、STEMI和PCI可识别有风险的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdc/8633847/dff9ffdca6d7/IJGM-14-8919-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdc/8633847/eea8a00a5ef1/IJGM-14-8919-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdc/8633847/dff9ffdca6d7/IJGM-14-8919-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdc/8633847/eea8a00a5ef1/IJGM-14-8919-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdc/8633847/dff9ffdca6d7/IJGM-14-8919-g0002.jpg

相似文献

1
Impact of Renal Insufficiency on Prognosis of Patients with Acute Coronary Syndrome.肾功能不全对急性冠状动脉综合征患者预后的影响。
Int J Gen Med. 2021 Nov 26;14:8919-8927. doi: 10.2147/IJGM.S334014. eCollection 2021.
2
Prognostic of different glomerular filtration rate formulas in patients receiving percutaneous coronary intervention: insights from a multicenter observational cohort.不同肾小球滤过率公式在接受经皮冠状动脉介入治疗患者中的预后:来自多中心观察队列的研究结果。
BMC Cardiovasc Disord. 2020 Jul 18;20(1):341. doi: 10.1186/s12872-020-01621-y.
3
Clinical outcomes after percutaneous coronary intervention in non-dialysis patients with acute coronary syndrome and advanced renal dysfunction.急性冠状动脉综合征合并严重肾功能不全的非透析患者经皮冠状动脉介入治疗的临床转归。
Clin Exp Nephrol. 2020 Apr;24(4):339-348. doi: 10.1007/s10157-019-01839-x. Epub 2020 Jan 6.
4
Prognostic significance of renal dysfunction and its change pattern on outcomes in patients with acute coronary syndrome treated with emergent percutaneous coronary intervention.肾功能不全及其变化模式对接受急诊经皮冠状动脉介入治疗的急性冠状动脉综合征患者预后的影响
Heart Vessels. 2019 May;34(5):735-744. doi: 10.1007/s00380-018-1291-5. Epub 2018 Nov 1.
5
The efficacy of Chinese herbal medicines on acute coronary syndrome with renal insufficiency after percutaneous coronary intervention.中药治疗经皮冠状动脉介入治疗后合并肾功能不全的急性冠状动脉综合征的疗效。
J Ethnopharmacol. 2020 Feb 10;248:112354. doi: 10.1016/j.jep.2019.112354. Epub 2019 Nov 2.
6
Prognostic comparison between creatinine-based glomerular filtration rate formulas for the prediction of 10-year outcome in patients with non-ST elevation acute coronary syndrome treated by percutaneous coronary intervention.基于肌酐的肾小球滤过率公式对经皮冠状动脉介入治疗的非 ST 段抬高型急性冠状动脉综合征患者 10 年预后的预测比较。
Eur Heart J Acute Cardiovasc Care. 2018 Dec;7(8):689-702. doi: 10.1177/2048872617697452. Epub 2017 Mar 15.
7
Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.稳定型冠心病合并慢性肾功能不全患者的长期预后:血管成形术或手术治疗 II 期试验的 10 年随访结果。
Nephrol Dial Transplant. 2020 Aug 1;35(8):1369-1376. doi: 10.1093/ndt/gfy379.
8
Long-term impact of mild chronic kidney disease in patients with acute coronary syndrome undergoing percutaneous coronary interventions.急性冠状动脉综合征行经皮冠状动脉介入治疗患者中轻度慢性肾脏病的长期影响。
Nephrol Dial Transplant. 2011 Sep;26(9):2906-11. doi: 10.1093/ndt/gfq820. Epub 2011 Feb 7.
9
Improved Renal Function After Percutaneous Coronary Intervention in Non-Dialysis Patients With Acute Coronary Syndrome and Advanced Renal Dysfunction.急性冠脉综合征合并中重度肾功能不全行非透析患者经皮冠状动脉介入术后肾功能改善。
Cardiovasc Revasc Med. 2021 Mar;24:26-30. doi: 10.1016/j.carrev.2020.09.011. Epub 2020 Sep 11.
10
Impact of baseline estimated glomerular filtration rate on inhospital outcomes of patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: A China acute myocardial infarction registry study.基线估计肾小球滤过率对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者住院结局的影响:一项中国急性心肌梗死注册研究。
Catheter Cardiovasc Interv. 2019 Feb 15;93(S1):793-799. doi: 10.1002/ccd.28060. Epub 2019 Jan 13.

引用本文的文献

1
Machine-learning based calculator for personalized risk assessment following ST-elevation myocardial infarction.基于机器学习的ST段抬高型心肌梗死后个性化风险评估计算器。
BMC Cardiovasc Disord. 2025 Aug 28;25(1):639. doi: 10.1186/s12872-025-04896-1.
2
Prognostic Value of Non-Traditional Lipid Indices for In-Hospital Mortality in Patients with Acute Coronary Syndromes.非传统血脂指标对急性冠脉综合征患者院内死亡率的预后价值
Medicina (Kaunas). 2025 May 4;61(5):846. doi: 10.3390/medicina61050846.
3
The relationship of the hemoglobin to serum creatinine ratio with long-term mortality in patients with acute coronary syndrome: A retrospective study.

本文引用的文献

1
Incidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation: a nationwide study.急性冠状动脉综合征伴首次检出心房颤动患者的缺血性卒中发生率和死亡率:一项全国性研究。
Eur Heart J. 2021 Nov 21;42(44):4553-4561. doi: 10.1093/eurheartj/ehab575.
2
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.KDIGO 2021慢性肾脏病血压管理临床实践指南执行摘要。
Kidney Int. 2021 Mar;99(3):559-569. doi: 10.1016/j.kint.2020.10.026.
3
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.
血红蛋白与血清肌酐比值与急性冠状动脉综合征患者长期死亡率的关系:一项回顾性研究。
Medicine (Baltimore). 2023 Oct 13;102(41):e35636. doi: 10.1097/MD.0000000000035636.
心脏病与中风统计-2021 更新:美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
4
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
5
Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China.肾功能不全与中国急性冠状动脉综合征患者治疗及结局的关系。
Int J Cardiol. 2021 Jan 15;323:7-12. doi: 10.1016/j.ijcard.2020.08.022. Epub 2020 Aug 15.
6
Impact of chronic kidney disease on mortality and cardiovascular outcomes after acute coronary syndrome: A nationwide data linkage study (ANZACS-QI 44).慢性肾脏病对急性冠状动脉综合征后死亡率和心血管结局的影响:一项全国性数据关联研究(ANZACS-QI 44)。
Nephrology (Carlton). 2020 Jul;25(7):535-543. doi: 10.1111/nep.13703. Epub 2020 Mar 12.
7
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家慢性肾脏病负担,1990-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13.
8
Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.慢性肾脏病与冠状动脉疾病:美国心脏病学会心血管介入治疗学会最新进展综述。
J Am Coll Cardiol. 2019 Oct 8;74(14):1823-1838. doi: 10.1016/j.jacc.2019.08.1017.
9
Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement: JACC International.中国心血管疾病的流行病学现状及改善机遇:《美国心脏病学会杂志:国际版》
J Am Coll Cardiol. 2019 Jun 25;73(24):3135-3147. doi: 10.1016/j.jacc.2019.04.036.
10
Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.慢性肾脏病程度对心肌梗死患者心脏治疗方法应用及预后的时间趋势变化:来自 NCDR 胸痛-MI 登记处的报告。
J Am Heart Assoc. 2018 Dec 18;7(24):e010394. doi: 10.1161/JAHA.118.010394.